Companies/XyloCor Therapeutics

XyloCor Therapeutics

HealthcareBiotech & Pharma

HQ: King of Prussia, United States

Investors: 1

Develops gene therapies for advanced coronary artery disease

Investors (1)

Fund	Status	Entry Date	Stage	Source
EQT	Current	-	-	Website

Get these signals delivered weekly

Deals, exits, fundraises, and key hires from funds active in Italy — straight to your inbox.